https://www.zacks.com/stock/news/2208083/medtronic-mdt-wins-ce-mark-for-minimed-780g-with-simplera-sync?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2208083
Jan 10, 2024 - Medtronic (MDT) secures the CE Mark for the MiniMed 780G system with the disposable, all-in-one Simplera Sync CGM.
zc:7791624660071069328
0
https://www.zacks.com/stock/news/2209712/here-s-why-you-should-retain-charles-river-crl-stock-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2209712
Jan 12, 2024 - Investors are optimistic about Charles River (CRL) owing to growth in the RMS and DSA segments and stable solvency position.
zc:-4362239090571522045
0
https://www.zacks.com/stock/news/2210890/here-s-why-investors-should-retain-bruker-brkr-stock-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2210890
Jan 16, 2024 - Investors are optimistic about Bruker (BRKR) on solid prospects of BSI Nano group and raised guidance.
zc:1579534077654882470
0
https://www.zacks.com/stock/news/2211621/here-s-why-investors-should-retain-resmed-rmd-stock-for-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2211621
Jan 17, 2024 - Investors are optimistic about ResMed (RMD) on strong uptake of the myAir app with AirSense11.
zc:-6817770391813950561
0
https://www.zacks.com/commentary/2224052/3-medical-services-stocks-to-buy-amid-industry-headwinds?cid=CS-ZC-FT-industry_outlook-2224052
Feb 09, 2024 - The Zacks Medical - Services industry is growing on digital healthcare adoption. ELV, COR and HQY are set to gain the most. However, staffing shortages continue to disrupt the growth trend.
zc:-5665982398767085151
0
https://www.zacks.com/stock/news/2232650/why-healthequity-hqy-is-poised-to-beat-earnings-estimates-again?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_7-2232650
Feb 27, 2024 - HealthEquity (HQY) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
zc:832671697970919989
0
https://www.zacks.com/stock/news/2234658/why-healthequity-hqy-is-a-top-momentum-stock-for-the-long-term?cid=CS-ZC-FT-tale_of_the_tape|zacks_education_momentum_score-2234658
Mar 01, 2024 - Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
zc:-426458265280102149
0
https://www.zacks.com/stock/news/2241382/are-you-a-growth-investor-this-1-stock-could-be-the-perfect-pick?cid=CS-ZC-FT-tale_of_the_tape|zacks_education_growth_score-2241382
Mar 15, 2024 - Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
zc:-4086040377222955638
0
https://www.zacks.com/stock/news/2242869/here-s-why-you-should-retain-healthequity-hqy-stock-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2242869
Mar 19, 2024 - HealthEquity's (HQY) strength in HSAs raises optimism about the stock.
zc:7712319095030402645
0
https://www.zacks.com/stock/news/2193838/healthequity-hqy-reports-q3-earnings-what-key-metrics-have-to-say?cid=CS-ZC-FT-fundamental_analysis|nfm-2193838
Dec 05, 2023 - While the top- and bottom-line numbers for HealthEquity (HQY) give a sense of how the business performed in the quarter ended October 2023, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
zc:2269088252084562923
0